A new RAND report shows nearly 12% of U.S. adults now use GLP-1 drugs like Ozempic and Wegovy, and it’s changing how they shop. Food companies say the biggest shift isn’t in portion sizes but in the ...

The impact of popular U. S. weight-loss drugs like Ozempic and Wegovy (GLP-1 receptor agonists), upon their initial ...

By Danny Barrett, Jr. University of Mississippi Medical Center JACKSON – Drugs initially approved for diabetes are now an ...

GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity or overweight with a related health condition. Read on for everything you need to know about GLP-1s for weight loss, ...

GLP-1 weight-loss drugs have already seen massive success in the US. While they've made some headway into the European market ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) like semaglutide and liraglutide mimic endogenous incretin signals to stimulate glucose-dependent insulin release, thereby suppressing glucagon, ...

Brooke Boyarsky Pratt, CEO, and Dr. Angela Fitch, chief medical officer, are both co-founders of knownwell. More than 12% of U.S. adults now take a GLP-1 medication, marking one of the ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks and ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...

Black and Latino people are less likely than white people to be prescribed GLP-1s for diabetes. Here's what studies reveal.

GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence suggests.

Today, the compounded GLP-1 market is in upheaval. The FDA has banned copies of GLP-1 weight loss drugs, and a number of ...